Timothy Eugene Sullivan serves as Executive at Apellis Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Timothy Eugene Sullivan has executed 52 insider transactions totaling $10.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 10, 2020 involved receiving (via award) 11,688 shares valued at $0.
Timothy Eugene Sullivan currently holds 93,901 shares of Apellis Pharmaceuticals, Inc. (APLS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Timothy Eugene Sullivan has been a net seller of APLS stock. They have purchased $347.6K and sold $10.6M worth of shares.
Timothy Eugene Sullivan's most recent insider trade was on Feb 10, 2020, when they sold 11,688 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $29.71 |
| Discretionary |